The αβ- andα2α1-globin mRNA ratios in different forms of α-thalassemia  by Smetanina, Natalia S. et al.
ELSEVIER Biochimica et Biophysica Acta 1315 (1996) 188-192 
BB 
Biochi~ie~a et Biophysica A~ta 
The and a2/a 1-globin mRNA ratios in different forms of 
a-thalassemia 
Natalia S. Smetanina a, Julia Y. Leonova a, Norman Levy b, Titus H.J. Huisman a,* 
a Laboratory of Protein Chemistry and Department ofBiochemistry and Molecular Biology Medical College of Georgia, Augusta, GA 30912-2100, USA 
b Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA 
Received 25 July 1995; revised 21 November 1995; accepted 6 December 1995 
Abstract 
The present study provides information about the a/[3 and a2 /a  1-mRNA ratios in reticulocytes of normal adults and individuals 
with different a-globin gene deficiencies; it found its origin in analytical data of blood samples from a Laotian couple and their newborn 
baby. The father carried the 4.2 kb deletion on one chromosome and a TAA ~ CAA mutation at the terminating codon of the a 2 gene 
(Hb Constant Spring or CS) on the other chromosome. The mother had the 3.7 kb deletion on one chromosome and a TA A ~ TAT 
mutation at the terminating codon of the a 2-globin gene (Hb Paks6) of the second chromosome. The baby was a compound heterozygote 
for the two termination codon mutations. The mRNA data for this family were compared to those for persons with several well-defined 
a-globin gene deficiencies. The results confirm the importance of the a 2 a 1-mRNA for the synthesis of a chains in a-thalassemia-2 
homozygotes ( - a~ - a) and in patients with Hb H disease due to the deletion of three a-globin genes ( -  a~ - - ). Furthermore, the 
mRNA production of the a 1-globin gene on the chromosome with the a cs mutation (a  csa) is only one-half of that by the a 2 a 1-globin 
gene of a chromosome with a 3.7 or 4.2 kb deletion, explaining the greater severity of, and higher Hb H level in Hb H patients with the 
aCSa condition (aCSa/ -  - )  as compared to those with the three gene deletion ( -a~-  - ) .  The methodology could be useful as a 
preliminary screening for the presence of point mutations leading to the functional loss of a single a-globin gene, provided common 
deletional alleles have been excluded. 
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1. Introduction 
We recently analyzed the a- and /3-globin gene muta- 
tions in a young Laotian couple, both with a marked 
microcytosis and hypochromia, and expecting their first 
baby. The final outcome of these analyses, reported else- 
where [1], showed that both adults were heterozygous for 
Hb E (/326(B8)Lys ~ Glu) and together carried five a- 
globin gene anomalies, namely, two a-thal-2 deletional 
determinants, two different terminating codon mutations, 
and Hb Q-Thailand (a  74(EF3)Asp ~ His) [2]. Initial anal- 
yses of their mRNA values, i.e., the a / /3  and a2/a l  
ratios, gave unexpectedly ow values that were difficult to 
understand without similar information for subjects with a 
well-defined and less complex set of a-globin gene defi- 
ciencies. We would like to report the results of these 
studies here. A number of factors play a role in the 
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decreases in the a/~ ratio that were observed, such as the 
level of a 1-mRNA which is normally much lower than 
that of the a2-mRNA but is translated more efficiently, 
the potential of increasing the level of a I -mRNA at least 
two-fold in situations where only one functional ce 1-globin 
gene remains, as in Hb H disease ( - - / -a ) ,  and the 
presence of an abnormal, elongated, a 2-mRNA produced 
by an a2-globin gene that is mutated at the terminating 
codon. The level of this abnormal a2-mRNA is greatly 
increased in nucleated red cells. 
2. Materials and methods 
Blood samples were collected in vacutainers with EDTA 
as anticoagulant and shipped by overnight mail service 
from New York, Lebanon, NH, and from Hawaii to Au- 
gusta, GA. Other samples were collected from members of 
families living in Georgia and South Carolina. In all 
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instances the material was kept on ice and refrigerated at 
4°C. Informed consent was obtained. Hematological values 
were determined with an automated cell counter and rou- 
tine laboratory procedures. Each sample was studied by 
isoelectrofocusing (IEF) [3], cation exchange high perfor- 
mance liquid chromatography (HPLC) [4], and reversed 
phase HPLC [5]. 
Total RNA was obtained from freshly collected blood 
with the method of Chomczynski and Sacchi [6] and 
Chomczynski [7]. Some 180 ng of this material was dena- 
tured for 3 min at 80°C and next reverse transcribed (RT) 
using the GeneAmp RNA-polymerase chain reaction (PCR) 
kit of Perkin Elmer Cetus (Norwalk, CT, USA). Five /zl 
aliquots contained the eDNA that served as a template for 
30 cycles of amplification with methodology slightly mod- 
ified from that described before [8-10]. Optimal results 
were obtained when the starting material was kept at less 
than 100 ng and the number of cycles did not exceed 30. 
The method used the 'hot-start' PCR procedure to avoid 
primer dimerization. The 1 × PCR buffer contained 2 mM 
MgC12, 0.2 mMol of each dNTP, 50 pMol of primer A, 25 
pMol of primers B, C, D and E, and 2.5 U Taq polymerase 
(Perkin Elmer Cetus) in a final volume of t00 /zl. Initial 
denaturation was for 5 min at 99°C; the enzyme was added 
at 'hot-start'. The amplification profile for each cycle 
consisted of denaturation for 1 min at 95°C, primer anneal- 
ing for 1 min at 64°C, and extension for 1 min at 72°C. 
The sequences of the primers and their locations are shown 
in Fig. 1. Primer sets A+B,  A+C,  and D+E are 
selected in such a way that an intron is located between 
them; absence of larger amplification products excludes 
the presence of contaminating genomic DNA. Fig. 2 pro- 
vides examples of separations by agar gel electrophoresis. 
PCR fragments were labelled by primer extension with 
,y_ 32 P-labelled primers A and D during one cycle of PCR 
[8,11 ]. The reaction mixture of 5 /zl PCR product, 20 pMol 
CAP CAP 
Ex-I EX-[I Ex-III EX-I EX-II 
-~ T -~ 
CAP 
Ex-I Exql [3 Ex-III 
5~..~ IS- ,VS-,I ]._3 
Location Relative 
to Cap Site 
Ex-III 
e 
$eqtlencos o# Pdmers 
A 5'-GGC AAG AAG GTG GCC GAC G-3' +332 to +350 (~t1; m?.) 
B 5'-GGG AGG CCC ATC GGG CAG GAG GAA C-3' ÷768to+744(a2) 
C 5'-GGG GGG AGG CCC AAG GGG CAA GAA-3' ÷778to+755(*×1) 
n 5'-CCT GTG GGG CAA GGT GAA-3' + 92 to +109 (i3) 
E 5-GAG CCA GGC CAT CAC TAA AG-3' +412 to +393 (~) 
Fragment Sizes 
02 Primers A+B DNA: 437 eDNA: 995 
~t PrimersA+C DNA:447 eDNA:298 
i] Primers D+E DNA: 322 eDNA: 192 
Fig. 1. Diagrams of the a- and 13-globin genes identifying the location of 
the five primers used in the amplification of the various eDNA samples. 
The sequences of the primers and the sizes of the fragments obtained are 




1` 1`  1` 1`  
192 295;298 192 295;298 
Fig. 2. Gel electrophoresis of fragments obtained in the PCR experiments. 
I: lane 2, 13 fragment (DE primers); lane 3, a 2 and a 1 fragments (ABC 
primer set); lane 4, a and 13 fragments (ABCDE primer set in one tube). 
eDNA from a normal person with four a-globin genes was used. II: lanes 
2, 3, 4, 5, 6, 7, eDNA from six normal persons (aa /ao~)  with primer 
set ABCDE. III: lane 2, eDNA from a person with three o~ genes 
( -a -37 /aa) ;  lane 3, that from a patient with Hb H disease 
(-- O/-3'7/-- --SEA); lane 4, that from an a-thai-2 homozygote 
(__ O~-37//__Ol 3.7); primer set ABCDE. Lanes I-1, II-1, and III-l: 
marker. 
y-32p-labelled primers A and D, 0.3 mMol/1 of each 
dNTP, 1 × MOPS, 2.5 U Taq polymerase (Perkin Elmer 
Cetus) in a final volume of 50/zl, was denatured for 5 min 
at 99°C (the Taq polymerase and the y_32 P-labelled primers 
were added during this period), followed by 1 min anneal- 
ing at 64°C and extension for 2 min at 72°C. Labelling of 
the primers (550 pMol) was with 5 /zl y-32 P-dATP (300 
Ci/mM, Amersham Intemational, Buckinghamshire, UK) 
and 30 U T4 polynucleotide kinase (New England Biolabs, 
Beverly, MA, USA). Three /~1 of the labelled PCR prod- 
ucts were analyzed on a non-denaturing 6% polyacryl- 
amide gel and auto-radiographed for l, 3, and 6 h to 
evaluate the possible error due to limited film capacity. 
Relative amounts of a- and /3-mRNAs were determined 
by densitometric s anning with a Shimadzu (Kobe, Japan) 
CS 9000 densitometer. 
The ratio of the a 2- and a 1-mRNAs was determined 
as described before [10]. Three /zl of the same labelled 
PCR products were digested with S tyI (Gibco-BRL, Grand 
Island, NY, USA) and next analyzed on a 6% polyacryl- 
amide-7 M urea gel. 
3. Results 
Patients. Analyses of blood samples from a Laotian 
family (father, mother, newborn baby girl) with multiple 
hemoglobin (Hb) abnormalities initiated the entire study. 
Characterization f their a- and /3-globin gene anomalies 
is described elsewhere [1]; the following abnormalities 
were present: Father T.S. /3 a//3 E ; _ a(4.2 kb deletion + 
Q-Thailand)/aCSa [12]; mother S.S. /3A//3E; --a(3.7 kb 
deletion)/aPa) (P = Paksr) [13]; baby S. /3E//3E; 
acsa/aPa. Both Hb CS and Hb Paks6 are the result of 
mutations at the terminating codon of the a 2-globin gene; 
Hb CS (codon 142, TAA ~ CAA) and Hb Paks~ (codon 
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142, TAA--* TAT) have an elongated a chain with a 
glutamine or tyrosine residue at codon 142, respectively. 
Additional blood samples were obtained from controls 
(seven with Hb AA, one AS, one SS; all nine had four 
c~-globin genes or a~/aa), six a-thal-2 heterozygotes 
( -  ce-3'7/c~c~) and three a-thal-2 homozygotes 
( -  c~- 3.7,/_ c~- 3.7), two c~-thal-2 heterozygotes 
( -a -42 /aa) ,  one heterozygote for Hb CS [12], eight 
ce-thal-1 heterozygotes (four with the SEA and four with 
the Fil deletions; for details see Ref. [14]), and five 
patients with Hb H disease (one with -ce 3.7/_ _SEA 
one with - a 4 .2 /__  __SEA one with - a 3.7/_ _Fil 
and two with otcsa/- SEA;  the latter two were transfu- 
sion-dependent). The controls and the --O~ -3 '7  hetero- 
zygotes and homozygotes were Caucasian and Black co- 
workers and/or patients, while the others were members 
of Oriental families living in Hawaii, New York, Georgia 
or South Carolina. Characterization f the various a gene 
deletions was with PCR-based methodology [15,16] or by 
gene mapping. The 3.7 kb deletion was the common type I 
[17]. 
mRNA analysis. The complex kinetics of amplification, 
including the amount of starting template and the number 
of amplification cycles, play an important role in standard- 
izing the procedure [ 18]. We therefore consistently used 30 
cycles of PCR and 45 ng of starting template and the same 
experimental conditions. Moreover, all five primers 
(ABCDE) were added to one tube allowing the simultane- 
ous determination of the c~//3 and ce2/c~l ratios, one 
295 (or2.) 
283 (eO) 
1 2 3 4 5 6 7 8 
Fig. 3. Separation of the RT-PCR products on a 6% polyacrylamide-urea 
gel. The fractions were digested with S tyI before application. Lanes 1 and 
6:ce-thal-2 homozygote ( -ce -37 / -  ce-3"7); lanes 2 and 7:ce-thal-2 
heterozygote ( -  o~-37/ceo~); lane 3: ce-thal-I heterozygote 
( - - - -SEA~ace);  lane 4: --ceQ(-42)/otCSce (father T.S.); lane 5: 
- ce 37~tePee (mother S.S.); lane 8: normal control (ac~/cece). 
serving as internal control for the other. Both mRNA ratios 
were determined for normal adults, a-thal-2 heterozygotes 
and homozygotes, a Hb CS heterozygote, a-thal-1 hetero- 
zygotes, and patients with Hb H disease. Some of the 
results are shown in Fig. 3, while the quantitative data are 
listed in Table 1. Repeat measurements gave comparable 
data; examples for the a//3-mRNA ratio are: Hb H pa- 
tients: 1.12 and 1.06; 1.10 and 0.86; 1.17 and 1.10; normal 
adults: 3.91 and 4.31; 4.40 and 4.76; 3.85 and 4.19. The 
average a/fl ratio for normal adults (ce/fl 4.33) is higher 
than that of 2.52 reported by Lin et al. [19] who used 
different sets of primers and other experimental conditions, 
and similar to the 4.5 reported by Chami et al. [20] who 
also used different sets of primers but included a synthetic 
internal standard. The average value for the c~2/al- 
Table 1 
The a/E -  and ce 2/ce 1-mRNA ratios in reticulocytes from normal 
(individual values with average values in parentheses) 
adults and adults with different ypes of ce-Thal determined with the RT-PCR procedure 
Condition ce-Globin genotype ce/ f l -mRNA ratio o~ 2/ce I-mRNA ratio 
Normal cea/cece 4.06; 4.11; 4.34; 4.58; 4.77; 3.10; 3.00; 3.05; 2.85; - - - ;  
4.46; 4.02; 4.74; 3.89 (4.33) 2.45; - - - ;  - - - ;  2.71 (2.86) 
c~-Thal-2 trait - ce/cece 3.82; 4.13; 4.01 ; 3.41 ; 3.40; 1.29; 1.39; 1.32; 1.30; 2.09; 
( -3 .7  kb) 3.37 (3.69) t.64 (1.51) 
ce-Thal-2 trait - ce/cece 3.40; 3.24 (3.32) 1.69; 1.81 (1.75) 
( - 4.2 kb) 
ce-Thal-2 hom. -ce / -  ce 1.41; 1.05; 1.31 (1.26) 0:1; 0:l; 0:1 
( - 3.7 kb) 
o~-Thal-2 trait o~csa/cece 2.93 2.06 
(Hb CS) 
ce-Thal-1 het. - - / cece  2,44; 2.60; 2.70; 2.48 (2,55) 2.51; 2.83; 2.51; 2.95 (2.70) 
(SEA) 
o~-Thal-1 bet. - - /ace  2.18; 2.55; 2.22; 2.53 (2.37) 2.79; 2.80; 2.98; 2.72 (2.82) 
(Fil.) 
Hb H disease -ce -3 .7 / _  _ SEA 0.98 0:I 
__ ce-4 2/__ __ SEA 1.09 0:1 
__0/-3.?//__ F i l  1.14 0:1 
ce CSCe/- --SEA 0.53; 0.60 (0.57) 0.18; 0.23 (0.20) 
Father S olCSo~/- ce 42 1.48 0.12 
Mother S cePce/- ce- 37 1.37 0.29 
Baby S a cecsce/ce Poe 3.17 (c~/fl E) 1.41 
0.68 (a / I f l  z + 7]) 
a The ce/[ fiE + 7] ratio in Baby S was calculated from the values of ce/fl and f l /7  [11]; unfortunately, no RT-PCR method has yet been developed 
allowing amplification of ot 2, eel, fl, and y in one tube. 
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mRNA ratio of 2.86 is comparable to that obtained by 
Molchanova et al. [10]. A decrease in a/ /3 ratio was 
found for -c~-3 7 /c~ heterozygotes (average 3.69 with a 
wide range) and a somewhat greater decrease for 
-c~-42/c~c~ heterozygotes (average 3.32); the ~x2/c~l 
ratios in these two types of c~-thal-2 trait were decreased to 
approximately the same value (1.51-1.75). The three ho- 
mozygotes for the - c~(3.7 kb) c~-thal-2 deletion had a low 
average c~//3 ratio of 1.26 and an c~ 2/ce 1 ratio of zero. 
The presence of the TAA --* CAA mutation at codon 142 
of the c~2 gene (Hb CS heterozygote) decreased the ce//3 
ratio from ~ 4.3 for c~c~/c~ce to 2.9, and the c~2/c~1 ratio 
from ~ 2.85 to 2.06. The elimination of the ce2- and 
c~ l-globin genes from one chromosome (i.e., the c~-thal-1 
heterozygote) resulted in a nearly 50% decrease in c~//3 
ratio, while the ce2/c~l ratio was the same as in the 
normal controls (c~c~/c~c~). The three patients with Hb H 
disease due to deletion of three c~-globin genes had c~//3 
ratios between 1.0 and 1.15, while the ce2/c~l ratios were 
zero. 
The o~//3 ratios in the two patients with Hb H disease 
and Hb CS (c~CSc~/- _SEA) were even lower (average 
0.57), while the c~ 2/o~ 1 ratios (average 0.20) pointed to a 
most modest level of o~CS-mRNA. The two adult members 
of the S family had o~//3 ratios similar to those observed 
for o~-thal-2 homozygotes (-o~ 3.7/_ c~-3.7), while their 
o~2/c~1 ratio (see also Fig. 3) was different (0.1-0.3 
instead of zero), suggesting a low level of c~ 2-mRNA. The 
[c~2 + c~l]/[/~E + y] for the newborn baby was 0.68 (the 
baby is homozygous for the /3E mutation), while the 
o~2/o~1 ratio of 1.41 is many times higher than expected 
from the ratios of 0.1-0.3 observed in the parents. 
4. Discussion 
The system developed for the quantitation of the c~//3- 
mRNA ratio is simple and reproducible. The amplification 
of the ce 2- and ce 1-mRNAs results in segments that are 
295 (c~ 1) and 298 (c~ 2) bp long and are quite different 
from the 192 bp fragment that results from the amplifica- 
tion of the /3-mRNA (Fig. 1). As shown, repeat experi- 
ments gave closely identical data but variations between 
persons with identical c~-globin gene arrangements are 
often quite large (Table 1; average value for nine normal 
persons: 4.33 with a range of 3.89-4.77). The deletion of 
one c~-globin gene in the c~-thal-2 heterozygotes is accom- 
panied by a modest but significant decrease in the c~//3- 
mRNA ratio (P  = 0.003); the large variation in values for 
the carriers with the 3.7 kb deletion, however, is unex- 
pected and in need of further evaluation. The ce 2/c~ 1 ratio 
in these conditions is low as expected [10]. Homozygosity 
for the 3.7 kb deletion results in a low c~//3-mRNA level 
of 1.26 which is about 30% of the value for normal adults 
with four c~-globin genes (c~ce/c~ce). Transcription of the 
remaining (ce2c~l) hybrid gene, however, provides an 
c~ I-mRNA that is translationally 2.5 to 3 times as active as 
the normal c~ 2-mRNA. Thus, the synthesis of c~ chains in 
these a-thal-2 homozygotes will be of the same level as 
that seen in the c~-thal-I heterozygotes with c~//3-mRNA 
ratios of approximately 2.5 (Table 1). The c~//3-mRNA 
ratios of 0.98-1.14 in the three patients with Hb H disease 
due to the deletion of three c~-globin genes is higher than 
expected. The one remaining (~ 2 c~l) hybrid gene or c~l 
gene apparently doubles its mRNA production, nearly 
equaling that seen in the c~-thal-2 homozygotes. This 
observation is in line with some clinical data; patients with 
this type of Hb H disease are able to maintain a functional 
Hb level of 8-9 g/dl  and often have a limited excess of/3 
chains or Hb H [21,22]. 
None of the three members of Family S, nor the two 
patients with Hb H disease and Hb CS (c~CSc~/- _SEA), 
produce normal c~2-mRNA; the terminating codon muta- 
tions are responsible for the formation of an abnormal, 
elongated, mRNA that likely uses the TAA sequence of 
the normal AATAAA poly(A) sequence as terminating 
codon and the cryptic poly(A) sequence at 1048 bp past 
the (mutated) terminating codon 142 as its poly(A) site 
(for references ee Ref. [23]). This mRNA is almost non- 
functional and translates into an extended c~ chain which 
in reticulocytes of heterozygotes amounts to less than 1%, 
while its level is considerably higher in bone marrow cells 
[21,24]. The ce 2/c~ l-mRNA ratios for father and mother S 
(with olCSol/-- O~ 42 or olPol/- C~ -37) and the two pa- 
tients with Hb H-Hb CS disease (c~CSo~/-_SEA) were 
about the same (~ 0.20), which is surprising because of 
two intact c~l- (or c~2o~1) globin genes in the former. It 
may well be that any difference, if present, is too small to 
be observed with the method that was used. A distinct 
difference, however, was seen in the c~//3 ratio. The 
average value of 0.57 for the two Hb H-Hb CS patients 
was about one-third of that of father and mother S (aver- 
age 1.43) and nearly one-half of that of 1.07 for the three 
Hb H patients with deletions of three a-globin genes 
( -o~/ -  - ) .  This agrees with the observations that Hb H 
patients with o~CS/- - are clinically more severely af- 
fected than those with -c~/ -  - and also have a higher 
level of Hb H ([22], and references quoted). It also sug- 
gests that the mRNA produced by the c~ 1-globin gene on 
the chromosome with the a cs mutation is considerably 
less than that by the (ol 2 o~ 1) hybrid gene or the c~ 1-globin 
gene of a chromosome with the 3.7 kb or the 4.2 kb 
deletion. 
The data obtained for baby S are also most revealing 
showing a greatly increased level of the elongated c~2 
message (the a2/c~ I-mRNA ratio in this infant is ~ 1.4 
as compared to 0.1-0.3 in the parents). There is evidence 
from earlier publications [24-26] that the Hb CS mRNA 
level in the bone marrow of Hb CS homozygotes is 
relatively high but its instability results in a gradual de- 
crease during erythroid maturation. The high level of 
abnormal c~ 2-mRNA in baby S likely originates from the 
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nucleated red cells that approximated 7% of the total red 
cell population of the cord blood sample. 
The methodology described here might be used as a 
preliminary screening procedure to detect the functional 
loss of a single a-globin gene caused by a non-deletional 
c~-thal allele, provided the presence of the common dele- 
tional types has been excluded. 
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